Li Lab

XIAOXIAN LI, MD, PHD
Professor
Department of Pathology and Laboratory Medicine
E-mail Dr. Li | View Dr. Li's Faculty Profile

Dr. Xiaoxian (Bill) Li is Professor of Pathology, Director of Breast Pathology, Director of Immunohistochemistry Laboratory and Co-Director of Anatomic Pathology Research. As the Director of Breast Pathology, Dr. Li supports a group of 7 breast pathology faculty. The pathology Immunohistochemistry Laboratory performs 300-350 tests per day. As the Director of Immunohistochemistry Laboratory, Dr. Li oversees the laboratory operation to ensure high quality patient care and research. As the Co-Director of AP research, Dr. Li co-lead the AP research committee to promote research and academic endeavor in the department.

Dr. Li obtained his medical degree from Beijing Medical University and a PhD from The University of Maryland, College Park. Dr. Li completed his AP/CP residency training at The Methodist Hospital in Houston and an oncologic pathology fellowship and a breast pathology fellowship at the MD Anderson Cancer Center. Dr. Li was inducted to the Emory University MilliPub Club twice for two of his seminal first-author papers in the field of breast cancer (PMID: 18445819, PMID: 19666588) which have been cited >1300 and >1000 times, respectively, per Web of Science. Dr. Li has >80 peer-reviewed publications, review articles and several book chapters. Dr. Li is a principal investigator or co-principal investigator of 6 active institutional, NIH, DOD, foundation and industrial grants, and is the Emory PI of a newly awarded R01 grant that received a study section score in the top 1 percentile. The current research interests of Dr. Li’s laboratory are focused on developing biomarkers to predict breast cancer risk, prognosis and response to therapies.

Dr. Li initiated and has been co-chairing the breast high-risk lesion conference at Emory since 2015, which has spared hundreds of patients from unnecessary surgery. He has also served on the Emory University School of Medicine Faculty Committee on Appointment and Promotions (FCAP), Emory Winship Breast Center Strategic Plan Steering Committee, Emory Pathology departmental FCAP Committee, Faculty Mentoring Committee, Incentive Plan Committee, Workload in AP Task Force Committee and Digital Pathology Steering Committee. Dr. Li is the current Co-Chair of the Faculty Affair Committee of the Emory School of Medicine Asian American and Pacific Islander (AAPI) Medical Faculty Association Affinity Group. At the national level, Dr. Li is a standing member of an American Cancer Society Grant Review Committee, and Ad Hoc grant reviewer for NIH, NCI, DOD, and Breast Cancer Now, England. Dr. Li is an Associate Editor of Breast Cancer Research and Treatment and Section Editor for breast pathology of the Archives of Pathology and Laboratory Medicine and Human Pathology Reports. He sits on the Editorial Board of Human Pathology and Clinical Breast Cancer. Dr. Li has been the lead pathologist of multiple national clinical trials in breast cancer. Dr. Li currently serves in multiple national committees, including committees of College of American Pathologists (CAP), CAP Foundation, Food and Drug Administration (FDA), International Society of Breast Pathology and I-SPY2 Trial Pathology Working Group. Dr. Li has mentored numerous PhD students, residents, fellows and visiting scholars and has been frequently invited to give lectures at national/international conferences including the CAP and USCAP annual meetings.